TAO Synergies Inc. (TAOX)
About TAO Synergies Inc.
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $299.1K
- Net income
- -$28.7M
- Total assets
- $25.8M
- Market cap
- $28.5M
- Gross margin
- 87.2%
- Operating margin
- -3025.2%
- Net margin
- -9609.2%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $299.1K
- Cost of revenue
- $38.3K
- Gross profit
- $260.8K
- Operating expenses
- $9.3M
- Operating income
- -$9.0M
- Income tax
- $0
- Net income
- -$28.7M
- EPS (basic)
- $-8.81
- EPS (diluted)
- $-8.81
Balance sheet
- Total assets
- $25.8M
- Current assets
- $25.4M
- Total liabilities
- $3.9M
- Current liabilities
- $1.8M
- Shareholders’ equity
- $21.1M
Cash flow
- Operating cash flow
- -$6.4M
- Investing cash flow
- -$28.9M
- Financing cash flow
- $23.1M
- Net cash flow
- -$12.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $28.5M
- EPS (diluted)
- $-8.81
- Shares outstanding
- 8.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 7, 2020
TAO Synergies Inc. (TAOX) Stock Price
- Reported a net loss of $28.7M in FY2025.
- Gross margin of 87.2%, net margin -9609.2%.
- Trading 68% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review TAO Synergies Inc..
Write a review
TAO Synergies Inc.: frequently asked questions
Is TAO Synergies Inc. an American company?
TAO Synergies Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is TAO Synergies Inc. headquartered?
TAO Synergies Inc. is headquartered in New York, New York, United States.
Is TAO Synergies Inc. publicly traded?
Yes — TAO Synergies Inc. is a publicly traded company. Its stock trades under the ticker symbol TAOX on the NASDAQ.
What does TAO Synergies Inc. do?
TAO Synergies Inc. is an American Financial Services company in the Business & Financial Services sector.
